We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Microsoft to Reprogram Diseased Cells to 'Solve' Cancer
Read MoreHide Full Article
Microsoft Corporation (MSFT - Free Report) recently announced that it intends to “solve” cancer within the next decade by the use of computer programming.
Microsoft’s Take on Cancer
Just like a virus affected PC requires an antivirus to debug it, Microsoft is planning to take on the disease of cancer by reprogramming the diseased cells into healthy cells.
In other words, Microsoft is planning to develop a chip made of human DNA that can be placed inside the cells. It can then identify the diseased cells and then get rid of the same by rebooting the computer.
In order to achieve the desired results, Microsoft has already started roping in some of the best biologists from all over the world who will work at its laboratory in the UK.
Competition
We note that there is fierce competition in the oncology space with the presence of major tech players such as International Business Machines Corporation (IBM - Free Report) and Alphabet Inc. (GOOGL - Free Report) owned Google. While IBM with its Watson Oncology project is working on targeted medicine, Microsoft’s attempt to develop a programmable cell will be the first of its kind.
Moreover, following the footprint of Google’s DeepMind, which has played a pivotal role in the treatment of neck and head cancers, Microsoft intends to use artificial intelligence in radiology through the use of machine vision tools to analyze CT scans for tumors.
Our Take
Though the cure for the ‘king of maladies’ could take some time to develop and reach the masses, Microsoft’s approach toward the disease is unique and holds promise.
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Microsoft to Reprogram Diseased Cells to 'Solve' Cancer
Microsoft Corporation (MSFT - Free Report) recently announced that it intends to “solve” cancer within the next decade by the use of computer programming.
Microsoft’s Take on Cancer
Just like a virus affected PC requires an antivirus to debug it, Microsoft is planning to take on the disease of cancer by reprogramming the diseased cells into healthy cells.
In other words, Microsoft is planning to develop a chip made of human DNA that can be placed inside the cells. It can then identify the diseased cells and then get rid of the same by rebooting the computer.
In order to achieve the desired results, Microsoft has already started roping in some of the best biologists from all over the world who will work at its laboratory in the UK.
Competition
We note that there is fierce competition in the oncology space with the presence of major tech players such as International Business Machines Corporation (IBM - Free Report) and Alphabet Inc. (GOOGL - Free Report) owned Google. While IBM with its Watson Oncology project is working on targeted medicine, Microsoft’s attempt to develop a programmable cell will be the first of its kind.
Moreover, following the footprint of Google’s DeepMind, which has played a pivotal role in the treatment of neck and head cancers, Microsoft intends to use artificial intelligence in radiology through the use of machine vision tools to analyze CT scans for tumors.
Our Take
Though the cure for the ‘king of maladies’ could take some time to develop and reach the masses, Microsoft’s approach toward the disease is unique and holds promise.
MICROSOFT CORP Price
MICROSOFT CORP Price | MICROSOFT CORP Quote
Zacks Rank & Key Picks
At present, Microsoft carries a Zacks Rank #3 (Hold).
A better-ranked stock in the broader technology space is Avid Technology, Inc. sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>